Angela Shen MD, MBA serves as Vice President of Strategic Innovation Leaders at Mass General Brigham, where responsibilities include heading regulatory efforts for the MGB Gene and Cell Therapy Institute and leading the clinical and translational market segment. With extensive experience in the biotech and pharmaceutical industries, Angela has held key roles such as Chief Medical Officer at Arcellx, Nkarta, and Arvinas, contributing to CAR-T technology and targeted protein degradation therapeutics. As an advisor to Walking Fish Therapeutics, Angela's focus is on engineered B-cell therapies, while consulting for Cell Therapy Accelerator LLC involves providing clinical strategy for various cell therapies. Angela's educational background includes an MD from Albany Medical College and an MBA from NYU Stern School of Business.
This person is not in the org chart
This person is not in any teams